We are live on ! Find out more

3,328 hedge funds and large institutions have $158B invested in Merck in 2025 Q2 according to their latest regulatory filings, with 179 funds opening new positions, 1,298 increasing their positions, 1,536 reducing their positions, and 252 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $2.52B | Put options by funds: $2.44B

0.28% less ownership

Funds ownership: 78.7%78.42% (-0.28%)

3% less funds holding

Funds holding: 3,4483,328 (-120)

13% less capital invested

Capital invested by funds: $181B → $158B (-$22.6B)

15% less repeat investments, than reductions

Existing positions increased: 1,298 | Existing positions reduced: 1,536

29% less first-time investments, than exits

New positions opened: 179 | Existing positions closed: 252

35% less funds holding in top 10

Funds holding in top 10: 6542 (-23)

Holders
3,328
Holders Change
-120
Holders Change %
-3.48%
% of All Funds
43.81%
Holding in Top 10
42
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-35.38%
% of All Funds
0.55%
New
179
Increased
1,298
Reduced
1,536
Closed
252
Calls
$2.52B
Puts
$2.44B
Net Calls
+$82.4M
Net Calls Change
-$173M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$20B +$31.9M +401,045 +0.2%
BlackRock
2
BlackRock
New York
$17.3B -$561M -7,057,399 -3%
State Street
3
State Street
Massachusetts
$9.47B -$162M -2,035,776 -2%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.08B -$383M -4,813,159 -6%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$4.65B -$56M -704,589 -1%
Charles Schwab
6
Charles Schwab
California
$4.26B +$369M +4,636,183 +9%
Morgan Stanley
7
Morgan Stanley
New York
$3.5B +$86.3M +1,086,242 +3%
Norges Bank
8
Norges Bank
Norway
$2.86B -$168M -2,116,401 -6%
JP Morgan Chase
9
JP Morgan Chase
New York
$2.52B +$263M +3,313,550 +12%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$2.5B -$19.2M -241,918 -0.8%
BC
11
Broadwater Capital
Massachusetts
$2.36B +$185M +2,331,519 +7,776%
Northern Trust
12
Northern Trust
Illinois
$2.28B -$131M -1,645,437 -5%
Bank of America
13
Bank of America
North Carolina
$2.22B -$243M -3,063,111 -10%
Franklin Resources
14
Franklin Resources
California
$2.14B +$408M +5,135,748 +23%
UBS AM
15
UBS AM
Illinois
$1.99B +$349M +4,395,852 +21%
Fisher Asset Management
16
Fisher Asset Management
Washington
$1.98B +$45.1M +567,900 +2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$1.74B -$90.1M -1,133,427 -5%
Legal & General Group
18
Legal & General Group
United Kingdom
$1.54B -$20.1M -252,263 -1%
Arrowstreet Capital
19
Arrowstreet Capital
Massachusetts
$1.54B +$405M +5,094,088 +35%
Goldman Sachs
20
Goldman Sachs
New York
$1.46B +$320M +4,024,221 +28%
Amundi
21
Amundi
France
$1.36B +$275M +3,454,941 +26%
Deutsche Bank
22
Deutsche Bank
Germany
$1.35B -$169M -2,129,824 -11%
Invesco
23
Invesco
Georgia
$1.35B +$137M +1,725,036 +11%
UBS Group
24
UBS Group
Switzerland
$1.34B -$331M -4,160,455 -20%
State Farm Mutual Automobile Insurance
25
State Farm Mutual Automobile Insurance
Illinois
$1.09B

MRK Hedge Fund Activity: Q2 2025 in Review

3,328 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2025, worth a combined $158B — down 13% from $181B a quarter earlier.

Sellers outnumbered buyers: 252 funds closed out of MRK and 179 opened new positions — a net loss of 73 holders — while 1,536 trimmed existing stakes and 1,298 added.

The largest buyer was Franklin Resources, adding an estimated $408M. The largest seller was Raymond James Financial, cutting an estimated $636M.

  • 3,328 institutional investors held Merck (MRK) as of Q2 2025, down from 3,448 in Q1 2025.
  • Funds reported $158B of Merck stock for Q2 2025, down 13% quarter-over-quarter.
  • 179 funds opened new Merck positions in Q2 2025 and 252 closed out, a net change of -73 holders.
  • The largest Merck buyer in Q2 2025 was Franklin Resources, an estimated $408M added.
  • The largest Merck seller in Q2 2025 was Raymond James Financial, an estimated $636M sold.

Based on aggregated 13F filings for Q2 2025.